Signify Premium Insights – Generative AI

Written by

Alan Stoddart headshot
Alan Stoddart
Ask an analyst
Request a quote
Request a brochure
Request a sample
Sign in
Signify Premium Insight
30 Apr 2024: Digital Health
SPI Digital Health: Swedish Vendor Has Designs on US RPM Profit
Swedish device manufacturer PMD Device Solutions (PMDS) plans to achieve profitability in the US in...
Arrow Right
Signify Premium Insight
26 Apr 2024: Digital Health
SPI Digital Health: Cegedim, Doctolib and the Race for French Primary Care IT Share
French vendors Cegedim and Doctolib have different opportunities and challenges ahead as they...
Arrow Right
Signify Premium Insight
26 Apr 2024: Healthcare IT
SPI Medical Imaging: Brainomix Study Demonstrates the Power of Pharma Partnerships for AI
A recent study resulting from a research collaboration between Brainomix and AstraZeneca...
Arrow Right

Share article:

A subscription to Signify Premium Insights – Generative AI provides compelling, actionable and up-to-the-moment analysis of the most pertinent developments in one of healthcare's most exciting areas of innovation. Leveraging Signify Research's wealth of market data, alongside its formidable analyst expertise, Signify Premium Insights contextualises industry-changing announcements to aid strategic planning and decision-making.

Subscribers to Signify Premium Insights – Generative AI receive approximately 100 actionable and up-to-the-moment Premium Insights per year, as well as access to Signify Research’s research portal, and all previous SPI-Gen AI Insights.

These Insights allow you to:

 

  • Make informed business decisions in response to changes in your market
  • Revise business plans and react to breaking industry developments
  • Strategise with greater certainty thanks to a more nuanced understanding of changing market dynamics
  • Identify lucrative opportunities more quickly, and capitalise on them with greater efficacy and with reduced research time